Moro, M., Bertolini, G., Pastorino, U., Roz, L., & Sozzi, G. (2015). Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133(+) Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung Cancer. J Thorac Oncol.

Moro, Massimo, Giulia Bertolini, Ugo Pastorino, Luca Roz, and Gabriella Sozzi. "Combination Treatment With All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133(+) Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung Cancer." J Thorac Oncol 2015.

Moro, Massimo, et al. "Combination Treatment With All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133(+) Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung Cancer." J Thorac Oncol 2015.